Auto-Injector Pen Archives

FDA approves Novartis’ Kesimpta

Adults, Approvals, Auto-Injector Pen, B Cells, Clinical Trials, FDA, FDA/Regulatory, Injections, R&D, Relapsing Multiple Sclerosis (RMS)

The U.S. Food and Drug Administration approved Novartis’ Kesimpta (ofatumumab, formerly OMB157) as an injection for subcutaneous use for the treatment of relapsing forms of multiple sclerosis in adults.

August 20, 2020/by PR Newswire

FDA green lights AstraZeneca’s asthma drug Fasenra for self-administration

Approvals, Asthma, Auto-Injector Pen, Doctors, Eosinophilic Esophagitis, FDA, FDA/Regulatory, Pre-Filled Pens

The U.S. Food and Drug Administration approved self-administration of AstraZeneca’s asthma treatment Fasenra which uses a pre-filled, single-use auto-injector pen.

October 4, 2019/by Reuters Health